Transferrin-modified doxorubicin-loaded biodegradable nanoparticles exhibit enhanced efficacy in treating brain glioma-bearing rats

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 9, 2013, Pages 691-696

  Liu, Guodong ^a   Mao, Jinning ^a   Jiang, Zirong ^b   Sun, Tao ^c   Hu, Yunfeng ^d   Jiang, Zhen ^a   Zhang, Caiyuan ^a   Dong, Jun ^a   Huang, Qiang ^a   Lan, Qing ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Changyi People's Hospital   (China)

^c XI AN JIAOTONG LIVERPOOL UNIVERSITY   (China)

^d SOUTH CHINA SEA INSTITUTE OF OCEANOLOGY   (China)

Author keywords

chemotherapy; doxorubicin; glioma; nanoparticle; transferrin

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; DOXORUBICIN; NANOPARTICLE; TRANSFERRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; EVAPORATION; GLIOMA; GLIOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BRAIN NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOXORUBICIN; DRUG CARRIERS; ENDOCYTOSIS; GLIOMA; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NEOPLASM TRANSPLANTATION; RATS; SINCALIDE; SOLVENTS; TRANSFERRIN;

EID: 84885662487     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2013.1480     Document Type: Article

References (22)

1. Behin A, Hoang-Xuan K, Carpentier AF, et al. Primary brain tumours in adults. Lancet 2003;361:323.
2. Caruso G, Raudino G, Caffo M, et al. Nanotechnology platforms in diagnosis and treatment of primary brain tumors. Recent Pat Nanotechnol 2010;4:119.
3. Ding H, Inoue S, Ljubimov AV, et al. Inhibition of brain tumor growth by intravenous poly (b-L-malic acid) nanobioconjugate with pH-dependent drug release. Proc Natl Acad Sci USA 2010;107:18143.
4. Huang FY, Lee TW, Kao CH, et al. Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model. Imaging, autoradiography, and biodistribution of (188)Relabeled PEGylated nanoliposome in orthotopic glioma bearing rat model. Cancer Biother Radiopharm 2011;26: 717.
5. Gao X, Tao W, Lu W, et al. Lectin-conjugated PEG-PLA nanoparticles: Preparation and brain delivery after intranasal administration. Biomaterials 2006;27:3482.
6. Daniels TR, Delgado T, Helguera G, et al. The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006;121:159.
7. Calzolari A, Larocca LM, Deaglio S, et al. Transferrin receptor 2 is frequently and highly expressed in glioblastomas. Transl Oncol 2010;3:123.
8. Lu W, Zhang Y, Tan YZ, et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 2005;107:428.
9. Agrawal P, Gupta U, Jain NK. Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials 2007;28:3349.
10. Olivier JC, Huertas R, Lee HJ, et al. Synthesis of pegylated immunonanoparticles. Pharm Res 2002;19:1137.
11. Pan H, Han L, Chen W, et al. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes. J Control Release 2008;125:228.
12. Pang Z, Gao H, Yu Y, et al. Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjug Chem 2011;22:1171.
13. Tian W, Ying X, Du J, et al. Enhanced efficacy of functionalized epirubicin liposomes in treating brain gliomabearing rats. Eur J Pharm Sci 2010;41:232.
14. Tsutsui Y, Tomizawa K, Nagita M, et al. Development of bionanocapsules targeting brain tumors. J Control release 2007;122:159.
15. Skarlatos S, Yoshikawa T, Pardridge WM, Transport of [125I]transferrin through the rat blood-brain barrier. Brain Research 1995;2:164.
16. Chang J, Paillard A, Passirani C, et al. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Pharm Res 2012;29:1495.
17. Zhang P, Hu L, Yin Q, et al. Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy. Mol Pharm 2012;9:1590.
18. Liu Y, Lu WL, Guo J, et al. A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J Control Release 2008;129:18.
19. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329.
20. Gref R,Minamitake Y, PeracchiaMT, et al. Biodegradable longcirculating polymeric nanospheres. Science 1994;263:1600.
21. Li Y, He H, Jia X, et al. A dual-targeting nanocarrier based on poly(amidoamine)dendrimers conjugatedwith transferrinand tamoxifenfor treatingbraingliomas.Biomaterials 2012;33:3899.
22. Ying X, Wen H, Lu WL, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 2010;141:183.